Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021866

ABILIFY (ARIPIPRAZOLE)
9.75MG/1.3ML (7.5MG/ML) Marketing Status: Discontinued

Active Ingredient: ARIPIPRAZOLE
Proprietary Name: ABILIFY
Dosage Form; Route of Administration: INJECTABLE; INTRAMUSCULAR
Strength: 9.75MG/1.3ML (7.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021866
Product Number: 001
Approval Date: Sep 20, 2006
Applicant Holder Full Name: OTSUKA PHARMACEUTICAL CO LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English